Why the study?
Does high platelet aggregation predict cardiovascular events in stable coronary artery disease patients treated with aspirin?
Does high platelet aggregation predict cardiovascular events in stable coronary artery disease patients treated with aspirin?
In patients with stable coronary artery disease on aspirin monotherapy, high platelet aggregation levels do not predict future cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Research meaning:* Leaves open whether other biomarkers better predict residual risk in this population.
Larsen et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: